Page last updated: 2024-08-17

androstenedione and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

androstenedione has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, B; Andersen, P; Bisgaard, H; Damkjaer Nielsen, M; Foged, N; Fuglsang, G; Høst, A; Leth, C; Pedersen, M; Pelck, I1

Trials

1 trial(s) available for androstenedione and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide.
    The Journal of allergy and clinical immunology, 1988, Volume: 81, Issue:6

    Topics: Adolescent; Adrenal Cortex Function Tests; Androstenedione; Asthma; Beclomethasone; Budesonide; Child; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydrocortisone; Male; Pituitary-Adrenal Function Tests; Pregnenediones; Prospective Studies; Random Allocation

1988